Efficacy of Cantharidin in Molluscum Contagiosum

• Status: Completed
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The University of North Carolina Department of Dermatology is conducting a clinical trial to evaluate a drug called cantharidin in the treatment of molluscum contagiosum. Molluscum is a common dermatologic disorder caused by a poxvirus. Molluscum typically presents with many flesh-colored bumps on the skin. It goes away on its own, though can last several months to several years. Cantharidin is a topical medicine which is applied at the clinic visit. It is well tolerated by the majority of children.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of North Carolina, Chapel Hill
• Collaborators: Doris Duke Charitable Foundation; National Center for Research Resources (NCRR)
• Treatments: Cantharidin

Criteria

Inclusion Criteria:

• Anyone aged 5-10 years with the clinical diagnosis of molluscum contagiosum.

Exclusion Criteria:

• Anyone with immunosuppression including HIV or previous organ transplantation.

• Anyone taking immunosuppressive medications.

• Anyone who has previously received treatment with cantharidin.

• Any female who has had her first menstrual period.